ArticleMolecules (Basel, Switzerland)2019
Bio-Polyethylene-Based Composites Reinforced with Alkali and Palmitoyl Chloride-Treated Coffee Silverskin.
Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Design and Characterization of Sustainable PLA-Based Systems Modified with a Rosin-Derived Resin: Structure-Property Relationships and Functional Performance.Biomimetics (Basel, Switzerland) · 2025Article
- Review
- Revalorization of Coffee Residues: Advances in the Development of Eco-Friendly Biobased Potential Food Packaging.Polymers · 2023Review
- Spent Coffee as a Composite Filler for Wastewater Treatment.Materials (Basel, Switzerland) · 2023Article
- Evaluation of Physico-Mechanical Properties on Oil Extracted Ground Coffee Waste Reinforced Polyethylene Composite.Polymers · 2022Article
- Upgrading Recycled Polypropylene from Textile Wastes in Wood Plastic Composites with Short Hemp Fiber.Polymers · 2021Article
- Coffee By-Products and Their Suitability for Developing Active Food Packaging Materials.Foods (Basel, Switzerland) · 2021Review
- By-Products from Food Industry as a Promising Alternative for the Conventional Fillers for Wood-Polymer Composites.Polymers · 2021Article
- Influence of Epoxy Resin Treatment on the Mechanical and Tribological Properties of Hemp-Fiber-Reinforced Plant-Derived Polyamide 1010 Biomass Composites.Molecules (Basel, Switzerland) · 2021Article
- Fabrication and Characterization of Microcellular Polyurethane Sisal Biocomposites.Molecules (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This work investigates the feasibility of using coffee silverskin (CSS) as a reinforcing agent in biobased polyethylene (BioPE) composites, by adding it in bulk and thin film samples. The effect of two different treatments, alkali bleaching (CSS_A) and esterification with palmitoyl chloride (CSS_P), on mechanical, thermal, morphological and water absorption behavior of produced materials at different CSS loading (10, 20 and 30 wt %) was investigated. A reactive graft copolymerization of BioPE with maleic anhydride was considered in the case of alkali treated CSS. It was found that, when introduced in bulk samples, improvement in the elastic modulus and a reduction in strain at maximum stress were observed with the increase in CSS fraction for the untreated and treated CSS composites, while the low aspect ratio of the CSS particles and their poor adhesion with the polymeric matrix were responsible for reduced ductility in films, decreasing crystallinity values and reduction of elastic moduli. When CSS_A and CSS_P are introduced in the matrix, a substantial reduction in the water uptake is also obtained in films, mainly due to presence of maleated PE, that builds up some interactions to eliminate the amounts of OH groups and hydrophobized CSS, due to the weakened absorption capacity of the functionalized CSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.